Co-Authors
This is a "connection" page, showing publications co-authored by Christopher Seymour and Erin McCreary.
Connection Strength
0.346
-
Sensible Medicine-Balancing Intervention and Inaction During the COVID-19 Pandemic. JAMA. 2020 11 10; 324(18):1827-1828.
Score: 0.228
-
The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization. Trials. 2021 May 25; 22(1):363.
Score: 0.059
-
Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Open Forum Infect Dis. 2021 Jul; 8(7):ofab254.
Score: 0.059